Newsroom Stories

Researchers at the School of Medicine have discovered that the ability to interact with other elements of the immune system is an indispensable part of the effectiveness of monoclonal antibodies. The findings could help improve the design of the next generation of COVID-19 drugs.

An international team of researchers, including scientists at the School of Medicine, has formed a network to study the role of inflammation in heart disease, with a goal of finding new therapies to improve recovery after heart attacks.

New research is exposing how lenders prioritized Paycheck Protection Program loan applications from businesses with prior lending relationships or personal connections to bank executives.

“Poorly Understood: What America Gets Wrong About Poverty,” a new book by Mark Rank, a leading academic expert on poverty at Washington University in St. Louis, explores the idealized image of American society.

Biologist Himadri Pakrasi in Arts & Sciences leads a team awarded $1.7 million from the National Science Foundation to streamline the genome of a cyanobacterium for sustainable production of food, feed and fuels.

Now more than ever, it’s important to understand issues from different perspectives. The American Democracy Lab podcast aims to do just that.

Researchers at Washington University School of Medicine in St. Louis have developed a liquid biopsy — examining blood or urine — that could help guide treatment for colorectal cancer patients.

Holocaust studies scholar Erin McGlothlin has been named vice dean of undergraduate affairs in Arts & Sciences, announced Feng Sheng Hu, the Lucille P. Markey Distinguished Professor and dean of the Faculty of Arts & Sciences.

Research from the lab of Kimberly Parker at the McKelvey School of Engineering reveals how certain, toxic byproducts of hydraulic fracturing are created. The next step is to determine whether or not there’s something to be done about it.

A new study led by the School of Medicine has mapped out detailed molecular and genetic schematics of glioblastoma, an aggressive brain tumor, opening the door to potential improved therapies.